October 19, 2017
Formerly the animal facility laboratory supervisor at the Africa Health Research Institute in Durban, South Africa, Chivonne Moodley is now joining a Tulane University tuberculosis research team.
October 13, 2017
Tulane researchers Robert Garry and James Robinson won’t give up until they unravel the mystery of the Lassa virus, saving lives from a severe and often fatal hemorrhagic fever that infects more than 300,000 people annually and is wrecking West African communities.
October 10, 2017
Tulane University’s Shantz Lab has received a two-year grant of $110,000 from the American Chemical Society’s (ACS) Petroleum Research Fund to find a solution to one of the chemical industry's most demanding transformations, the direct conversion of benzene to phenol.
October 03, 2017
Tulane University’s Laura Schrader, a cell and molecular biology professor and Brain Institute member, received a two-year grant from the National Institute of Health to study the role of a Shox2, a protein in the brain important for development and function of the thalamus.
September 27, 2017
For 15 years, students enrolled in summer fellowships at the Tulane National Primate Research Center have gained first-hand experience in scientific research and veterinary medicine.
September 26, 2017
The National Institutes of Health has awarded Tulane University a five-year, $6.28 million grant to test ways to best implement new guidelines to more aggressively manage high blood pressure in adults, especially among low-income patients at high risk for cardiovascular disease.
September 26, 2017
A Tulane University geologist has concluded a study on climate change, which will help develop climate models that simulate the effects of climate change and the Earth’s response to it.
September 19, 2017
Members of Tulane University’s Shantz Lab will work with industrial scientists to assist in the development of next-generation materials designed to reduce harmful automotive emissions. The three-year-old lab and its group of students have received a grant and equipment resources from SACHEM, Inc., a chemical science company.
September 13, 2017
Tulane University researchers have developed a new drug that is effective against non-severe cases of malaria, according to results from an FDA-supervised clinical trial published online in The Lancet Infectious Diseases.